Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy of prostatitis syndrome].

F M Wagenlehner1, K G Naber

  • 1Urologische Klinik, Klinikum St. Elisabeth, Akademisches Lehrkrankenhaus, Technische Universität München, St. Elisabeth-Strasse 23, 94315 Straubing. wagenlehner@aol.com

Der Urologe. Ausg. A
|February 28, 2001
PubMed
Summary

Chronic prostatitis syndrome has unknown causes, with treatments varying by type. Bacterial prostatitis benefits from antibiotics, while chronic pelvic pain syndrome (CPPS) management is complex and may involve alpha-blockers or other therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Linguistic validation and cognitive assessment of the French version of the Acute Cystitis Symptom Score questionnaire.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

Additional assessment of Acute Cystitis Symptom Score questionnaire for patient-reported outcome measure in female patients with acute uncomplicated cystitis: part II.

World journal of urology·2019
Same author

[Urogenital tuberculosis and schistosomiasis (bilharzia) : Urological challenges in displaced persons].

Der Urologe. Ausg. A·2018
Same author

Nitroxoline in geriatric patients with lower urinary tract infection fails to achieve microbiologic eradication: a noncomparative, prospective observational study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

[What is the perception of the 10-point plan of the German Federal Ministry of Health against multidrug-resistant pathogens and measures of antibiotic stewardship? : An interdisciplinary analysis among German clinicians and development of a decision tool for urologists].

Der Urologe. Ausg. A·2017
Same author

[Are there alternatives to antimicrobial therapy and prophylaxis of uncomplicated urinary tract infections?]

Urologiia (Moscow, Russia : 1999)·2017

Area of Science:

  • Urology
  • Infectious Diseases
  • Pain Management

Context:

  • Chronic prostatitis syndrome is a complex condition with multifactorial origins and largely unknown etiology.
  • The NIH classification distinguishes between acute/chronic bacterial prostatitis and chronic pelvic pain syndrome (CPPS).
  • CPPS is further categorized into inflammatory and non-inflammatory subtypes, with uncertain infectious origins for the inflammatory form.

Purpose:

  • To outline current therapeutic strategies for chronic prostatitis syndrome based on its classification.
  • To discuss the role of antimicrobial therapy in bacterial prostatitis versus CPPS.
  • To highlight the importance of alpha-receptor blockers for bladder neck obstruction and the consideration of alternative treatments.

Summary:

  • Bacterial prostatitis requires long-term antimicrobial therapy, typically fluoroquinolones.

Related Experiment Videos

  • Chronic pelvic pain syndrome (CPPS) management is varied; antibiotics are not a first choice but may help in combination with alpha-blockers.
  • Alpha-receptor blockers are recommended for bladder neck obstruction, with psychosomatics considered if other treatments fail.

    • Impact:

    • Provides a framework for understanding and managing different forms of prostatitis.
    • Emphasizes the need for tailored treatment approaches based on accurate diagnosis.
    • Underscores the importance of patient-therapist communication in navigating complex treatment challenges.